PANBELA THERAPEUTICS INC by Panbela Therapeutics, Inc. (PBLA) Stock Price, Quote, News & History | Benzin - Benzinga

PANBELA THERAPEUTICS INC by Panbela Therapeutics, Inc. (PBLA) Stock Price, Quote, News & History

PBLAOTCEM

Trade with Public

Trade with Public

$1.11

At close: Mar 15, 5:00 PM EST

$0.00020

-1.11-99.98%

After Hours: Mar 16, 4:56 PM EST

OverviewNews Earnings Forecast Events Price Targets Financials Sentiment Ownership Compare

Key Statistics

Open

-

Close

-

Volume / Avg.

0 / 1.53K

Day Range

- - -

52 Wk Range

0.00 - 2.50

Market Cap

-

P/E Ratio

-

Dividend Yield

-

Exchange

OTC

RSI

-

Short Interest

-

Days to Cover

1

Recent Panbela Therapeutics Inc News

Top 4 Health Care Stocks That Are Preparing To Pump This Month

The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.

Avi Kapoor

What's Going On With Panbela Therapeutics Stock Today?

Panbela Therapeutics announced acceptance of SBP-101 abstract for presentation and disclosed details of a public offering, expecting approximately $9.0 million in gross proceeds.

Nabaparna Bhattacharya

Crude Oil Down Over 1%; Science 37 Holdings Shares Spike Higher

U.S. stocks traded slightly higher toward the end of trading, with the Nasdaq Composite gaining around 75 points on Monday. The Dow traded up 0.03% to 38,121.11 while the NASDAQ rose 0.48% to 15,529.84. The S&P 500 also rose, gaining, 0.19% to 4,900.27.

Avi Kapoor

Why Panbela Therapeutics Shares Are Trading Lower By 65%? Here Are Other Stocks Moving In Monday's Mid-Day Session

Shares of Panbela Therapeutics, Inc. (NASDAQ: PBLA) fell sharply during Monday’s session after the company announced pricing of a roughly $9 million public offering. Panbela Therapeutics shares dipped 65.5% to $1.47 on Monday.

Avi Kapoor

Dow Edges Lower; Cardlytics Shares Jump

U.S. stocks traded mixed midway through trading, with the Nasdaq Composite gaining around 20 points on Monday. The Dow traded down 0.04% to 38,093.41 while the NASDAQ rose 0.15% to 4,891.83. The S&P 500 also rose, gaining, 0.02% to 4,891.83.

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-15.57M

Investing Cash Flow (TTM)

775.00K

Financing Cash Flow (TTM)

14.03M

Free Cash Flow (TTM)

-15.57M

Capital Expenditure (TTM)

-

Net Change in Cash (TTM)

-767.00K

Analyst Rating and Forecast

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$6.25M

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

-

PB Ratio (TTM)

-

Earnings Yield % (TTM)

-34510000.00%

Earnings Yield % (FWD)

-

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

-$3.74

Company Debt

Total Debt

$6.39M

LT Debt

$3.19M

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-

Total Cash

$142.00K

Debt to Equity

-

Issuance of Debt (TTM)

-

Repayment of Debt (TTM)

-$1.00M

Key Statistics

Open

-

Close

-

Volume / Avg.

0 / 1.53K

Day Range

- - -

52 Wk Range

0.00 - 2.50

Market Cap

-

P/E Ratio

-

Dividend Yield

-

Exchange

OTC

RSI

-

Short Interest

-

Days to Cover

1

About

Sector

Health Care

Industry

Biotechnology

Panbela Therapeutics Inc is a clinical-stage biopharmaceutical company developing disruptive therapeutics for the treatment of patients with urgent unmet medical needs. The Company's pipeline assets are ivospemin (SBP-101), FlynpoviTM (eflornithine (...

Show More

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

Q

How do I buy PANBELA THERAPEUTICS INC by Panbela Therapeutics, Inc. (PBLA) stock?

A

You can purchase shares of PANBELA THERAPEUTICS INC by Panbela Therapeutics, Inc. (OTCEM:PBLA) through any online brokerage.

View our list of the best stock brokerages

Q

Who are PANBELA THERAPEUTICS INC by Panbela Therapeutics, Inc. (PBLA) competitors?

A

There are no as such competitors for PANBELA THERAPEUTICS INC by Panbela Therapeutics, Inc..

Q

What is the forecast, or price target, for PANBELA THERAPEUTICS INC by Panbela Therapeutics, Inc. (PBLA) stock?

A

PANBELA THERAPEUTICS INC by Panbela Therapeutics, Inc. has a consensus price target of $25.00.

Q

What is the current price for PANBELA THERAPEUTICS INC by Panbela Therapeutics, Inc. (PBLA)?

A

The stock price for PANBELA THERAPEUTICS INC by Panbela Therapeutics, Inc. (OTCEM: PBLA) is $0.0002 last updated March 16, 2026 at 4:56 PM EDT.

Q

Does PANBELA THERAPEUTICS INC by Panbela Therapeutics, Inc. (PBLA) pay a dividend?

A

There are no upcoming dividends for PANBELA THERAPEUTICS INC by Panbela Therapeutics, Inc..

Q

When is PANBELA THERAPEUTICS INC by Panbela Therapeutics, Inc. (OTCEM:PBLA) reporting earnings?

A

PANBELA THERAPEUTICS INC by Panbela Therapeutics, Inc. does not have any upcoming earnings scheduled.

Q

Is PANBELA THERAPEUTICS INC by Panbela Therapeutics, Inc. (PBLA) going to split?

A

There is no upcoming split for PANBELA THERAPEUTICS INC by Panbela Therapeutics, Inc..

Q

What sector and industry does PANBELA THERAPEUTICS INC by Panbela Therapeutics, Inc. (PBLA) operate in?

A

PANBELA THERAPEUTICS INC by Panbela Therapeutics, Inc. is in the Health Care sector and Biotechnology industry. They are listed on the OTCEM.